Alimera Sciences(ALIM)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ALIM Alimera Sciences

停牌 09-13 16:00:00 EDT

5.54

+0.00

0.00%

最高5.54	最低5.54	成交量0.00
今开5.54	昨收5.54	日振幅0.00%
总市值3.01亿	流通市值7,301万	总股本5,438万
成交额1,485万	换手率0.00%	流通股本1,318万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ALIM","market":"US","secType":"STK","nameCN":"Alimera Sciences","latestPrice":5.54,"timestamp":1726257600000,"preClose":5.54,"halted":3,"volume":0,"delay":0,"floatShares":13178153,"shares":54384165,"eps":-0.311922,"marketStatus":"停牌","marketStatusCode":5,"change":0,"latestTime":"09-13 16:00:00 EDT","open":5.54,"high":5.54,"low":5.54,"amount":14852893.576992,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.311922,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1730797200000},"adr":0,"listingDate":1271908800000,"adjPreClose":5.54,"adrRate":0,"volumeRatio":0},"requestUrl":"/m/hq/s/ALIM","defaultTab":"news","newsList":[{"id":"2468584223","title":"BUZZ-Alimera 交易完成后，古根海姆上调 ANI 制药公司的预期收益率","url":"https://stock-news.laohu8.com/highlight/detail?id=2468584223","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468584223?lang=zh_cn&edition=full","pubTime":"2024-09-17 19:28","pubTimestamp":1726572511,"startTime":"0","endTime":"0","summary":"    9月17日 - ** 经纪公司古根海姆将ANI Pharmaceuticals   的PT值从77美元上调至83美元，维持 \"买入 \"评级** 新的PT较上一交易日收盘价上涨47.7 ** 称，在完成对Alimera公司的收购后更新了模型 ** 周一，ANIP宣布完成对Alimera Sciences   的收购，扩大了其罕见病业务。** 券商预计，Alimera 24财年的产品收入为3440万美元，其中包括ANIP将记录的2024年第三季度最后两周的410万美元销售额。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ANIP","ALIM"],"gpt_icon":0},{"id":"2466468453","title":"BUZZ--美国股票走势-Arrowhead Pharma、波音公司、Centessa Pharma","url":"https://stock-news.laohu8.com/highlight/detail?id=2466468453","media":"Reuters","labels":["Business Data"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466468453?lang=zh_cn&edition=full","pubTime":"2024-09-10 23:59","pubTimestamp":1725983967,"startTime":"0","endTime":"0","summary":"        *      Eikon 个股走势搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      9月10日 - 标普500指数和纳斯达克指数周二上涨，多数大盘股上涨，目前市场焦点转向本周晚些时候的关键通胀数据，该数据可能进一步明确美联储9月18日降息的预期幅度。美东时间11:34，道琼斯工业平均指数  下跌0.5%，报40,639.63点。标普500指数  上涨0.17%，报5480.53点；纳斯达克综合指数  上涨0.41%，报16954.15点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Business Data","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BKR","DDM","LU","RLAY","SIRI","ARWR","NEM",".IXIC","COR","PSX","RTX","FCX","RBRK","AU","SQQQ","F","XOM","DJX","WYNN","ALIM","HES","COP","NQmain","BA","UDOW","MNQmain","GE","DOG","CRH","ASO",".SPX","SDOW","VRDN","HPE","CVX","GM","MCK","CLF","KGS","PSQ",".DJI","CAH","QID","IONS","DXD"],"gpt_icon":1},{"id":"2466456331","title":"BUZZ-Alimera Sciences 下定决心起诉 ANI Pharma 以完成交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2466456331","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466456331?lang=zh_cn&edition=full","pubTime":"2024-09-10 21:52","pubTimestamp":1725976364,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    9月10日 - ** 眼科药物开发商Alimera Sciences   股价下跌16.67%，至4.61美元** 公司在 (link) 提起诉讼，要求 ANI 制药公司  完成合并交易** 该诉讼要求法院要求 ANI 履行其义务，按照协议的设想完成交易** 两家公司于 6 月宣布 (link) 他们的协议，ALIM 的预付对价估值约为 3.81 亿美元。** ALIM 今年以来的涨幅约为 6","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ALIM","ANIP"],"gpt_icon":0},{"id":"2457113813","title":"Alimera Sciences Inc 报告截至 6 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2457113813","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457113813?lang=zh_cn&edition=full","pubTime":"2024-08-08 21:51","pubTimestamp":1723125063,"startTime":"0","endTime":"0","summary":"   * Alimera Sciences Inc   报告，截至6月底的季度调整后每股亏损6美分，高于去年同期的每股收益1.32美元。四位分析师对该季度的平均预期是每股亏损 4 美分。华尔街预期为每股-6美分至-2美分。* Alimera Sciences Inc 公布的本季度每股收益为亏损 6 美分。* Alimera Sciences Inc 本季度股价下跌了 0.2%，今年迄今为止上涨了 28.5%。8月8日 - 预测变化   * 过去三个月，分析师的平均盈利预期下降了约 175.1%。华尔街对 Alimera Sciences Inc 的 12 个月目标价中位数为 5.50 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Alimera Sciences Inc 报告截至 6 月的季度业绩 - 收益摘要","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ALIM"],"gpt_icon":0},{"id":"2457077506","title":"Alimera Sciences Inc    预计每股亏损 1 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2457077506","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457077506?lang=zh_cn&edition=full","pubTime":"2024-08-07 02:36","pubTimestamp":1722969373,"startTime":"0","endTime":"0","summary":"   * Alimera Sciences Inc    将于8月8日公布截至2024年9月30日的财报(估计)，预计季度收入将有所增长。* 根据LSEG的数据，4位分析师的平均预期显示，这家总部位于佐治亚州阿尔法利塔的公司的营收预计将从去年同期的2336万美元增长17.4%，达到2743.8万美元。* LSEG 分析师对 Alimera Sciences Inc 的平均预期是每股亏损 1 美分。* 华尔街对 Alimera Sciences Inc 的 12 个月目标价中位数为 5.50 美元，低于其最新收盘价 5.55 美元。8月6日 - 以前季度业绩。除非另有说明，所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Alimera Sciences Inc    预计每股亏损 1 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALIM"],"gpt_icon":0},{"id":"2446282538","title":"Alliance Global Partners：下调Alimera Sciences(ALIM.US)评级，由买入调整至中性评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2446282538","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446282538?lang=zh_cn&edition=full","pubTime":"2024-06-25 23:17","pubTimestamp":1719328630,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["ALIM","BK4007"],"gpt_icon":0},{"id":"2446421708","title":"Alimera Sciences公司：全球合作伙伴将买入评级下调至中立。","url":"https://stock-news.laohu8.com/highlight/detail?id=2446421708","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446421708?lang=zh_cn&edition=full","pubTime":"2024-06-25 22:22","pubTimestamp":1719325377,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4007","ALIM"],"gpt_icon":0},{"id":"2446557843","title":"Maxim Group：下调Alimera Sciences(ALIM.US)评级，由买入调整至持有评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2446557843","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446557843?lang=zh_cn&edition=full","pubTime":"2024-06-25 20:47","pubTimestamp":1719319662,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4007","ALIM"],"gpt_icon":0},{"id":"2446819128","title":"HC Wainwright &amp; Co.：下调Alimera Sciences(ALIM.US)评级，由买入调整至中性评级, 目标价6.","url":"https://stock-news.laohu8.com/highlight/detail?id=2446819128","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446819128?lang=zh_cn&edition=full","pubTime":"2024-06-25 19:03","pubTimestamp":1719313399,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["ALIM","BK4007"],"gpt_icon":0},{"id":"2446860353","title":"美国研究综述-Alimera Sciences、Comtech Telecommunications、礼来公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2446860353","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446860353?lang=zh_cn&edition=full","pubTime":"2024-06-25 15:19","pubTimestamp":1719299996,"startTime":"0","endTime":"0","summary":"    路透6月25日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括 Alimera Sciences、Comtech Telecommunications 和礼来公司。要闻             * Alimera Sciences Inc   ：Craig-Hallum将其评级从 \"买入 \"下调至 \"持有\"。* Comtech Telecommunications Corp   ：杰富瑞将其评级从 \"表现不佳 \"上调至 \"持有\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2468319806.SGD","LLY","CTVA","BK4520","SUM","XAIR","LU1150488135.SGD","VMC","LU0053671581.USD","LU0128526141.USD","LU1852331112.SGD","EAT","LU0238689110.USD","POOL","CMTL","SNCY","BK4159","IE00B1BXHZ80.USD","WOLF","LU0456855351.SGD","LU1861220033.SGD","BK4539","LU1057294990.SGD","ZETA","LU1861215975.USD","LU0471298777.SGD","BK4011","LU0029874061.USD","BK4139","IE00BJT1NW94.SGD","AVAV","LU0061475181.USD","LU2237438978.USD","OMI","RXO","EXP","LU0266013472.USD","FMC","IONS","MLM","EPD","ALNY","ALIM","LU0289739699.SGD","BK4144","BK4590","FRPT","LU0708995401.HKD","OLLI","BK4023"],"gpt_icon":0},{"id":"2446000300","title":"BUZZ--美国股票走势-Arrowhead Pharmaceuticals、Nvidia、Alimera Sciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2446000300","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446000300?lang=zh_cn&edition=full","pubTime":"2024-06-25 01:58","pubTimestamp":1719251898,"startTime":"0","endTime":"0","summary":"        *      个股异动的 Eikon 搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      6月24日 - 周一，蓝筹股道指创下一个月新高，市场普遍反弹，投资者纷纷撤出与人工智能相关的股票，而市场焦点转向本周晚些时候公布的关键通胀数据，以加强对今年降息的押注。美东时间13:42，道琼斯工业平均指数  上涨0.65%，报39,405.62点。标普500指数  下跌0.01%，报5464.16点；纳斯达克综合指数  下跌0.69%，报17566.534点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DOG","BA","EOSE","LU0642271901.SGD","COIN","BK4528","LU0310800965.SGD","DDM","MU","SMCI","UDOW","RIOT","PYPL",".IXIC","RMD","NQmain","DJX","BK4529","IE00BDCRKT87.USD","SNV","BK4077","BUZZ","LU0109392836.USD","SQ","TQQQ","FDX","ARWR","NVDA","SQQQ","LU1316542783.SGD","QLD","IE00BJJMRY28.SGD","AFRM","MARA",".DJI","DXD","BK4575","MNQmain","NNE","QQQ","SDOW","QID","CARR","SON","MAX","ALNY","PSQ","LU0289961442.SGD","RXO","ALIM"],"gpt_icon":0},{"id":"2446004826","title":"BUZZ-因 ANI 制药公司被收购，Alimera 科学公司股价大涨近 80","url":"https://stock-news.laohu8.com/highlight/detail?id=2446004826","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446004826?lang=zh_cn&edition=full","pubTime":"2024-06-25 00:40","pubTimestamp":1719247214,"startTime":"0","endTime":"0","summary":"    6月24日 - ** ANI Pharmaceuticals   提出收购要约后，眼药开发商Alimera Sciences   的股价周一飙升79.3%，达到5.65美元。** ALIM创2022年10月以来新高。2024 年股价将上涨约 11%，目前市值约为 13 亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BUZZ","ALIM","BK4007","ANIP"],"gpt_icon":0},{"id":"2445749010","title":"Alimera Sciences, Inc.盘中异动 早盘大幅拉升76.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2445749010","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2445749010?lang=zh_cn&edition=full","pubTime":"2024-06-24 21:31","pubTimestamp":1719235881,"startTime":"0","endTime":"0","summary":"北京时间2024年06月24日21时31分，Alimera Sciences, Inc.股票出现异动，股价急速上涨76.59%。Alimera Sciences, Inc.股票所在的制药行业中，整体涨幅为0.14%。Alimera Sciences, Inc.公司简介：Alimera Sciences Inc 是一家商业化阶段制药公司，正在开发 ILUVIEN 并将其商业化，用于治疗糖尿病黄斑水肿，一种致盲原因，并在美国以外地区用于治疗影响眼球后段的非感染性葡萄膜炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062421312195d2b4c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062421312195d2b4c6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALIM","BK4007"],"gpt_icon":0},{"id":"2445075699","title":"【Alimera Sciences(ALIM.US)盘前暴涨超76%！获ANI Pharmaceuticals(ANIP.","url":"https://stock-news.laohu8.com/highlight/detail?id=2445075699","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2445075699?lang=zh_cn&edition=full","pubTime":"2024-06-24 20:16","pubTimestamp":1719231368,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["ANIP","ALIM","BK4007"],"gpt_icon":0},{"id":"2445075618","title":"Alimera Sciences(ALIM.US)盘前暴涨超76%！获ANI Pharmaceuticals(ANIP.US)收购 估值3.81亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2445075618","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2445075618?lang=zh_cn&edition=full","pubTime":"2024-06-24 20:16","pubTimestamp":1719231368,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，ANI Pharmaceuticals宣布，将以每股5.50美元的价格现金收购Alimera Sciences。受此消息提振，截至发稿，Alimera Sciences周一美股盘前涨超76%。ANI Pharmaceuticals表示，此次收购将进一步推动其罕见病业务，并预计该交易将在2025年实现调整后NON-GAAP每股收益的高个位数至低两位数增长，且此后将实现大幅增长。ANI Pharmaceuticals计划使用手头现金和债务融资相结合的方式为此次交易融资。资料显示，ANI Pharmaceuticals开发、制造和销售仿制药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1139706.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["ANIP","BK4007","ALIM"],"gpt_icon":0},{"id":"2445024085","title":"Alimera Sciences公司：每股5.50美元现金的拟议交易。","url":"https://stock-news.laohu8.com/highlight/detail?id=2445024085","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2445024085?lang=zh_cn&edition=full","pubTime":"2024-06-24 18:50","pubTimestamp":1719226256,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["ALIM","BK4007"],"gpt_icon":0},{"id":"2445791966","title":"Alimera Sciences, Inc.盘中异动 临近收盘快速上涨5.08%报3.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2445791966","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2445791966?lang=zh_cn&edition=full","pubTime":"2024-06-22 03:46","pubTimestamp":1718999215,"startTime":"0","endTime":"0","summary":"北京时间2024年06月22日03时46分，Alimera Sciences, Inc.股票出现波动，股价急速上涨5.08%。截至发稿，该股报3.21美元/股，成交量4.1437万股，换手率0.08%，振幅4.98%。Alimera Sciences, Inc.股票所在的制药行业中，整体跌幅为0.14%。Alimera Sciences, Inc.公司简介：Alimera Sciences Inc 是一家商业化阶段制药公司，正在开发 ILUVIEN 并将其商业化，用于治疗糖尿病黄斑水肿，一种致盲原因，并在美国以外地区用于治疗影响眼球后段的非感染性葡萄膜炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240622034656af8eaacb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240622034656af8eaacb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ALIM"],"gpt_icon":0},{"id":"2444745778","title":"Alimera Sciences, Inc.盘中异动 临近收盘大幅下跌5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2444745778","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2444745778?lang=zh_cn&edition=full","pubTime":"2024-06-19 03:38","pubTimestamp":1718739503,"startTime":"0","endTime":"0","summary":"北京时间2024年06月19日03时38分，Alimera Sciences, Inc.股票出现波动，股价大幅跳水5.23%。Alimera Sciences, Inc.股票所在的制药行业中，整体涨幅为0.54%。Alimera Sciences, Inc.公司简介：Alimera Sciences Inc 是一家商业化阶段制药公司，正在开发 ILUVIEN 并将其商业化，用于治疗糖尿病黄斑水肿，一种致盲原因，并在美国以外地区用于治疗影响眼球后段的非感染性葡萄膜炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240619033823941ef485&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240619033823941ef485&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALIM","BK4007"],"gpt_icon":0},{"id":"2444481191","title":"Alimera Sciences, Inc.盘中异动 股价大涨5.68%报3.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444481191","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2444481191?lang=zh_cn&edition=full","pubTime":"2024-06-18 00:01","pubTimestamp":1718640104,"startTime":"0","endTime":"0","summary":"北京时间2024年06月18日00时01分，Alimera Sciences, Inc.股票出现异动，股价快速拉升5.68%。Alimera Sciences, Inc.股票所在的制药行业中，整体涨幅为0.39%。Alimera Sciences, Inc.公司简介：Alimera Sciences Inc 是一家商业化阶段制药公司，正在开发 ILUVIEN 并将其商业化，用于治疗糖尿病黄斑水肿，一种致盲原因，并在美国以外地区用于治疗影响眼球后段的非感染性葡萄膜炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240618000145aef54c00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240618000145aef54c00&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ALIM"],"gpt_icon":0},{"id":"2443674516","title":"Alimera Sciences, Inc.盘中异动 早盘大幅拉升6.58%报3.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2443674516","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2443674516?lang=zh_cn&edition=full","pubTime":"2024-06-14 23:21","pubTimestamp":1718378496,"startTime":"0","endTime":"0","summary":"北京时间2024年06月14日23时21分，Alimera Sciences, Inc.股票出现异动，股价急速上涨6.58%。Alimera Sciences, Inc.股票所在的制药行业中，整体跌幅为0.06%。Alimera Sciences, Inc.公司简介：Alimera Sciences Inc 是一家商业化阶段制药公司，正在开发 ILUVIEN 并将其商业化，用于治疗糖尿病黄斑水肿，一种致盲原因，并在美国以外地区用于治疗影响眼球后段的非感染性葡萄膜炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614232139aef50bdb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614232139aef50bdb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALIM","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.alimerasciences.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":-0.0036},{"period":"6month","weight":0.5178},{"period":"1year","weight":0.6994},{"period":"ytd","weight":0.2824}],"compareEarnings":[{"period":"1week","weight":-0.0138},{"period":"1month","weight":0.0038},{"period":"3month","weight":0.0716},{"period":"6month","weight":0.1169},{"period":"1year","weight":0.3257},{"period":"ytd","weight":0.2014}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Alimera Sciences, Inc.在2003年6月4日成立于特拉华州，是一家生物制药公司。公司专门研究发展眼科处方药的商业化应用，目前主要致力于眼球后部结构以及视网膜的疾病感染方面。公司认为，这些疾病目前并没有受到很好地治疗，而这代表着一个巨大的市场有待开发。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":0.077931},{"month":2,"riseRate":0.642857,"avgChangeRate":0.18464},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.027021},{"month":4,"riseRate":0.5,"avgChangeRate":0.020755},{"month":5,"riseRate":0.266667,"avgChangeRate":-0.024382},{"month":6,"riseRate":0.6,"avgChangeRate":0.070859},{"month":7,"riseRate":0.466667,"avgChangeRate":0.027067},{"month":8,"riseRate":0.266667,"avgChangeRate":-0.082409},{"month":9,"riseRate":0.4,"avgChangeRate":-0.042716},{"month":10,"riseRate":0.571429,"avgChangeRate":-0.049731},{"month":11,"riseRate":0.642857,"avgChangeRate":-0.042422},{"month":12,"riseRate":0.285714,"avgChangeRate":0.024896}],"exchange":"NASDAQ","name":"Alimera Sciences","nameEN":"Alimera Sciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Alimera Sciences(ALIM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Alimera Sciences(ALIM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Alimera Sciences,ALIM,Alimera Sciences股票,Alimera Sciences股票老虎,Alimera Sciences股票老虎国际,Alimera Sciences行情,Alimera Sciences股票行情,Alimera Sciences股价,Alimera Sciences股市,Alimera Sciences股票价格,Alimera Sciences股票交易,Alimera Sciences股票购买,Alimera Sciences股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Alimera Sciences(ALIM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Alimera Sciences(ALIM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}